Weight loss injections primarily refer to glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications originally developed for type 2 diabetes management but now FDA-approved for chronic weight management in adults with BMI 30 kg/m (or 27 kg/m with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia)
Choose complex carbohydrates, such as whole grains, sweet potatoes, and beans, instead of refined ones
Once you stop taking semaglutide, tirzepatide, or other GLP-1 compounds, your appetite hormones return to baseline levels within weeks
For those seeking rapid, efficient muscular gains or recovery support, this 10-day cycle may provide a powerful toolwhen used with precision, strategy, and supervision.